These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Low dose streptozotocin causes diabetes in severe combined immunodeficient (SCID) mice without immune cell infiltration of the pancreatic islets. Reddy S; Wu D; Elliott RB Autoimmunity; 1995; 20(2):83-92. PubMed ID: 7578872 [TBL] [Abstract][Full Text] [Related]
5. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice. Herold KC; Baumann E; Vezys V; Buckingham F J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296 [TBL] [Abstract][Full Text] [Related]
6. Survival of intrasplenically implanted islets in mice with experimental insulitis and hyperglycemia. Sandler S; Andersson A Diabetes; 1982 Aug; 31 Suppl 4():78-83. PubMed ID: 6219904 [TBL] [Abstract][Full Text] [Related]
7. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection. Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223 [TBL] [Abstract][Full Text] [Related]
8. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus. Leiter EH Proc Natl Acad Sci U S A; 1982 Jan; 79(2):630-4. PubMed ID: 6210909 [TBL] [Abstract][Full Text] [Related]
9. A Novel Subcutaneous Site of Islet Transplantation Superior to the Liver. Yasunami Y; Nakafusa Y; Nitta N; Nakamura M; Goto M; Ono J; Taniguchi M Transplantation; 2018 Jun; 102(6):945-952. PubMed ID: 29521877 [TBL] [Abstract][Full Text] [Related]
10. Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells. Herold KC; Bloch TN; Vezys V; Sun Q Diabetes; 1995 Mar; 44(3):354-9. PubMed ID: 7883124 [TBL] [Abstract][Full Text] [Related]
11. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function. Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560 [TBL] [Abstract][Full Text] [Related]
12. Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice. Ohmura Y; Tanemura M; Kawaguchi N; Machida T; Tanida T; Deguchi T; Wada H; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Matsuura N; Ito T; Nagano H; Doki Y; Mori M Transplantation; 2010 Dec; 90(12):1366-73. PubMed ID: 21076379 [TBL] [Abstract][Full Text] [Related]
15. IL-12p40 is not required for islet allograft rejection. Bi EG; Shi W; Zou J; Hao ZH; Li ZH; Cai D; Zhang HQ; Sun B Acta Pharmacol Sin; 2006 Aug; 27(8):1065-70. PubMed ID: 16867260 [TBL] [Abstract][Full Text] [Related]
16. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice. Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475 [TBL] [Abstract][Full Text] [Related]
17. Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Gerling IC; Friedman H; Greiner DL; Shultz LD; Leiter EH Diabetes; 1994 Mar; 43(3):433-40. PubMed ID: 8314017 [TBL] [Abstract][Full Text] [Related]
18. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role. Meghana K; Sanjeev G; Ramesh B Eur J Pharmacol; 2007 Dec; 577(1-3):183-91. PubMed ID: 17900558 [TBL] [Abstract][Full Text] [Related]
19. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Wang Z; Gleichmann H Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374 [TBL] [Abstract][Full Text] [Related]
20. Fish oil-enriched diet and reduction of low-dose streptozocin-induced hyperglycemia. Inhibition of macrophage activation. Linn T; Noke M; Woehrle M; Kloer HU; Hammes HP; Litzlbauer D; Bretzel RG; Federlin K Diabetes; 1989 Nov; 38(11):1402-11. PubMed ID: 2533572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]